Publications of R. Hohlfeld
All genres
Journal Article (119)
21.
Journal Article
133, pp. 2182 - 2184 (2010)
Beneficial brain autoimmunity? Brain 22.
Journal Article
16 (4), pp. 376 - 377 (2010)
Molecular oracles for multiple sclerosis therapy. Nature Medicine 23.
Journal Article
67 (4), pp. 422 - 424 (2010)
Zero Tolerance (to Acetylcholine Receptor) and Ways to Overcome It. Annals of Neurology 24.
Journal Article
362 (5), pp. 387 - 401 (2010)
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis. New England Journal of Medicine 25.
Journal Article
16 (1), pp. 3 - 14 (2010)
'Gimme five': Future challenges in multiple sclerosis. ECTRIMS Lecture 2009. Multiple Sclerosis Journal 26.
Journal Article
132, pp. 3342 - 3352 (2009)
MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 27.
Journal Article
31 (4), pp. 467 - 477 (2009)
Novel approaches for identifying target antigens of autoreactive human B and T cells. Seminars in Immunopathology 28.
Journal Article
39 (8), pp. 2036 - 2039 (2009)
Multiple sclerosis: Human model for EAE? European Journal of Immunology 29.
Journal Article
106 (20), pp. 8302 - 8307 (2009)
Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals. Proceedings of the National Academy of Sciences of the United States of America 30.
Journal Article
66 (5), pp. 655 - 658 (2009)
Cross-reactive T-Cell Receptors in Tumor and Paraneoplastic Target Tissue. Archives of Neurology 31.
Journal Article
158 (3), pp. 1122 - 1132 (2009)
Neuro-immune crosstalk in CNS. Neuroscience 32.
Journal Article
274 (1-2), pp. 5 - 8 (2008)
B- and T-cell responses in multiple sclerosis: Novel approaches offer new insights. Journal of Neurological Sciences 33.
Journal Article
274 (1-2), pp. 42 - 44 (2008)
Compartmentalization of inflammation in the CNS: A major mechanism driving progressive multiple sclerosis. Journal of Neurological Sciences 34.
Journal Article
71 (17), pp. 1350 - 1354 (2008)
Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis. Neurology 35.
Journal Article
201-202, pp. 21 - 27 (2008)
Reflections on the "intrathymic pathogenesis" of myasthenia gravis. Journal of Neuroimmunology 36.
Journal Article
197 (2), pp. 128 - 139 (2008)
BDNF and its receptors in human myasthenic thymus: Implications for cell fate in thymic pathology. Journal of Neuroimmunology 37.
Journal Article
131, pp. 1455 - 1463 (2008)
Interferon-β increases BAFF levels in multiple sclerosis: Implications for B cell autoimmunity. Brain 38.
Journal Article
14 (6), pp. 688 - 693 (2008)
Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis. Nature Medicine 39.
Journal Article
265 (1-2), pp. 93 - 96 (2008)
Neurotrophic cross-talk between the nervous and immune systems: Relevance for repair strategies in multiple sclerosis? Journal of the Neurological Sciences 40.
Journal Article
35 (7), pp. 345 - 355 (2008)
Autoantigen- und erregerspezifische T- und B-Zellreaktionen bei multipler Sklerose: „Eine unendliche Geschichte”? Aktuelle Neurologie